Position in TYRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$389,624,082
-$77,583,255 QoQ
Shares Held
12,198,625
0.0% QoQ
Ownership
20.4%
of shares outstanding
% of Portfolio
3.43%
of 13F equity value
Holder Rank
#1
of 169 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TYRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RA CAPITAL MANAGEMENT, L.P. holds $11,082,969,028 across 75 Biotechnology names. TYRA ranks #6 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
10,281,496 | $2,742,280,613 | |
| 2 | PBLS |
Parabilis Medicines, Inc.
|
28,933,371 | $791,906,364 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
6,666,837 | $740,218,912 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
11,474,599 | $667,018,439 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
9,905,045 | $435,722,929 | |
| 6 | TYRA |
Tyra Biosciences, Inc.
This page
|
12,198,625 | $389,624,082 | |
| 7 | EWTX |
Edgewise Therapeutics, Inc.
|
8,392,730 | $340,996,619 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
|
9,883,524 | $330,779,298 |
All Filings in TYRA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $389,624,082 | 12,198,625 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $467,207,337 | 12,198,625 | Shares | Sole | 2026-05-15 | |
| 2026-03-04 | $432,642,100 | 12,266,575 | Shares | Sole | 2026-03-06 | |
| 2025-12-31 | $320,701,851 | 12,198,625 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $170,658,763 | 12,198,625 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $116,740,841 | 12,198,625 | Shares | Sole | 2025-08-14 | |
| 2025-06-04 | $122,091,824 | 11,899,788 | Shares | Sole | 2025-06-06 | |
| 2025-03-31 | $98,926,797 | 10,637,290 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $147,858,331 | 10,637,290 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $244,894,477 | 10,416,609 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $166,561,577 | 10,416,609 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $170,832,387 | 10,416,609 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $100,224,887 | 7,236,454 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $99,645,971 | 7,236,454 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $123,236,811 | 7,236,454 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $116,289,815 | 7,236,454 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $54,997,050 | 7,236,454 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $63,608,430 | 7,236,454 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $51,740,646 | 7,236,454 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $77,430,057 | 7,236,454 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $101,816,907 | 7,236,454 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $127,289,225 | 7,236,454 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||